Cargando…

A Nano-Emulsion Platform Functionalized with a Fully Human scFv-Fc Antibody for Atheroma Targeting: Towards a Theranostic Approach to Atherosclerosis

Atherosclerosis is at the onset of the cardiovascular diseases that are among the leading causes of death worldwide. Currently, high-risk plaques, also called vulnerable atheromatous plaques, remain often undiagnosed until the occurrence of severe complications, such as stroke or myocardial infarcti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bonnet, Samuel, Prévot, Geoffrey, Mornet, Stéphane, Jacobin-Valat, Marie-Josée, Mousli, Yannick, Hemadou, Audrey, Duttine, Mathieu, Trotier, Aurélien, Sanchez, Stéphane, Duonor-Cérutti, Martine, Crauste-Manciet, Sylvie, Clofent-Sanchez, Gisèle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8153629/ https://www.ncbi.nlm.nih.gov/pubmed/34068875 http://dx.doi.org/10.3390/ijms22105188

Ejemplares similares

A Recombinant Human Anti-Platelet scFv Antibody Produced in Pichia pastoris for Atheroma Targeting
por: Vallet-Courbin, Amelie, et al.
Publicado: (2017)

An innovative flow cytometry method to screen human scFv-phages selected by in vivo phage-display in an animal model of atherosclerosis
por: Hemadou, Audrey, et al.
Publicado: (2018)

Data on atherosclerosis specific antibody conjugation to nanoemulsions
por: Prévot, Geoffrey, et al.
Publicado: (2017)

By-Passing Large Screening Experiments Using Sequencing as a Tool to Identify scFv Fragments Targeting Atherosclerotic Lesions in a Novel In Vivo Phage Display Selection
por: Deramchia, Kamel, et al.
Publicado: (2012)

In Vivo Human Single‐Chain Fragment Variable Phage Display‐Assisted Identification of Galectin‐3 as a New Biomarker of Atherosclerosis
por: Hemadou, Audrey, et al.
Publicado: (2021)

Data on iron oxide core oil-in-water nanoemulsions for atherosclerosis imaging
por: Prévot, Geoffrey, et al.
Publicado: (2017)

Enhancing the detection of Toxoplasma gondii via an anti-SAG1 scFv-alkaline phosphatase immunoconjugate
por: Hannachi, Emna, et al.
Publicado: (2019)

Synthesis and Intracellular Uptake of Rhodamine–Nucleolipid Conjugates into a Nanoemulsion Vehicle
por: Cunha, Anthony, et al.
Publicado: (2020)

Identification of Potent CD19 scFv for CAR T Cells through scFv Screening with NK/T-Cell Line
por: Kang, Chung Hyo, et al.
Publicado: (2020)

scFv Antibody: Principles and Clinical Application
por: Ahmad, Zuhaida Asra, et al.
Publicado: (2012)

Pacific Biosciences Sequencing and IMGT/HighV-QUEST Analysis of Full-Length Single Chain Fragment Variable from an In Vivo Selected Phage-Display Combinatorial Library
por: Hemadou, Audrey, et al.
Publicado: (2017)

Nonspecificity in a nonimmune human scFv repertoire
por: Kelly, Ryan L., et al.
Publicado: (2017)

“Stapling” scFv for multispecific biotherapeutics of superior properties
por: Boucher, Lauren E., et al.
Publicado: (2023)

Isolation and characterization of human anti-CD20 single-chain variable fragment (scFv) from a Naive human scFv library
por: Shams, Nasir, et al.
Publicado: (2022)

The effects of N-terminal insertion into VSV-G of an scFv peptide
por: Dreja, Hanna, et al.
Publicado: (2006)

Empowering scFv with effector cell functions for improved anticancer therapeutics
por: Zhang, Hongtao
Publicado: (2013)

Integrating scFv into xMAP Assays for the Detection of Marine Toxins
por: Shriver-Lake, Lisa C., et al.
Publicado: (2016)

The Four-State Equilibrium Unfolding of a scFv Antibody Fragment
por: Pedroso, Idolka, et al.
Publicado: (2002)

Humanization and directed evolution of the selenium-containing scFv phage abzyme
por: Xu, Yan, et al.
Publicado: (2018)

Engineered Human Monoclonal scFv to Receptor Binding Domain of Ebolavirus
por: Densumite, Jaslan, et al.
Publicado: (2021)

Relative Contribution of Framework and CDR Regions in Antibody Variable Domains to Multimerisation of Fv- and scFv-Containing Bispecific Antibodies
por: Bhatta, Pallavi, et al.
Publicado: (2018)

Production and characterisation of a recombinant scFv reactive with human gastrointestinal carcinomas
por: Kim, D-J, et al.
Publicado: (2002)

Generation and Characterization of an scFv Directed against Site II of Rabies Glycoprotein
por: Aavula, Shukra M., et al.
Publicado: (2011)

Production of scFv-Conjugated Affinity Silk Powder by Transgenic Silkworm Technology
por: Sato, Mitsuru, et al.
Publicado: (2012)

Early Detection of NSCLC with scFv Selected against IgM Autoantibody
por: Pedchenko, Tetyana, et al.
Publicado: (2013)

Development and identification of fully human scFv-Fcs against Staphylococcus aureus
por: Nian, Siji, et al.
Publicado: (2016)

Development of Human-Like scFv-Fc Neutralizing Botulinum Neurotoxin E
por: Miethe, Sebastian, et al.
Publicado: (2015)

Targeting scFv-Fc-scTRAIL fusion proteins to tumor cells
por: Hutt, Meike, et al.
Publicado: (2018)

Targeting HER2-breast tumors with scFv-decorated bimodal nanoprobes
por: Alric, Christophe, et al.
Publicado: (2018)

Generation of a Fully Human scFv that binds Tumor-Specific Glycoforms
por: Lu, Zhongpeng, et al.
Publicado: (2019)

Characterization and analysis of scFv-IgG bispecific antibody size variants
por: Cao, Mingyan, et al.
Publicado: (2018)

Development and in vitro characterization of a humanized scFv against fungal infections
por: Di Mambro, Tomas, et al.
Publicado: (2022)

Bioinformatics in molecular immunology laboratories demonstrated: Modeling an anti-CMV scFv antibody
por: Heng, Chua Kek, et al.
Publicado: (2006)

Bacterial secretion of soluble and functional trivalent scFv-based N-terminal trimerbodies
por: Blanco-Toribio, Ana, et al.
Publicado: (2015)

Refolded scFv Antibody Fragment against Myoglobin Shows Rapid Reaction Kinetics
por: Song, Hyung-Nam, et al.
Publicado: (2014)

Cell-free eukaryotic systems for the production, engineering, and modification of scFv antibody fragments
por: Stech, Marlitt, et al.
Publicado: (2014)

A Novel Human scFv Library with Non-Combinatorial Synthetic CDR Diversity
por: Bai, Xuelian, et al.
Publicado: (2015)

Generation and characterization of a novel recombinant scFv antibody specific for Campylobacter jejuni
por: Nzuma, Ruramayi M., et al.
Publicado: (2018)

Isolation and identification of an scFv antibody against nucleocapsid protein of SARS-CoV
por: Zhao, Aizhi, et al.
Publicado: (2007)

Preparation of scFv stabilized chromatosomes for single-particle cryo-EM structure determination
por: Zhou, Bing-Rui, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h22lb4inf4s9ceij1r95rpbens